These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 32540405

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases.
    Michels MAHM, van de Kar NCAJ, Okrój M, Blom AM, van Kraaij SAW, Volokhina EB, van den Heuvel LPWJ.
    Front Immunol; 2018; 9():612. PubMed ID: 29670616
    [Abstract] [Full Text] [Related]

  • 5. A novel missense mutation in complement factor I predisposes patients to atypical hemolytic uremic syndrome: a case report.
    Wei X, Li J, Zhan X, Tu L, Huang H, Wang Y.
    J Med Case Rep; 2022 Mar 04; 16(1):101. PubMed ID: 35241161
    [Abstract] [Full Text] [Related]

  • 6. Diabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult: a case report.
    Zhu Z, Chen H, Gill R, Wang J, Spitalewitz S, Gotlieb V.
    J Med Case Rep; 2016 Feb 24; 10():38. PubMed ID: 26911616
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?
    Marinozzi MC, Vergoz L, Rybkine T, Ngo S, Bettoni S, Pashov A, Cayla M, Tabarin F, Jablonski M, Hue C, Smith RJ, Noris M, Halbwachs-Mecarelli L, Donadelli R, Fremeaux-Bacchi V, Roumenina LT.
    J Am Soc Nephrol; 2014 Sep 24; 25(9):2053-65. PubMed ID: 24652797
    [Abstract] [Full Text] [Related]

  • 10. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
    Szarvas N, Szilágyi Á, Csuka D, Takács B, Rusai K, Müller T, Arbeiter K, Réti M, Haris Á, Wagner L, Török S, Kelen K, Szabó AJ, Reusz GS, Morgan BP, Prohászka Z.
    Mol Immunol; 2016 Mar 24; 71():10-22. PubMed ID: 26826462
    [Abstract] [Full Text] [Related]

  • 11. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
    Yuan X, Gavriilaki E, Thanassi JA, Yang G, Baines AC, Podos SD, Huang Y, Huang M, Brodsky RA.
    Haematologica; 2017 Mar 24; 102(3):466-475. PubMed ID: 27810992
    [Abstract] [Full Text] [Related]

  • 12. A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome.
    Funato M, Uemura O, Ushijima K, Ohnishi H, Orii K, Kato Z, Yamakawa S, Nagai T, Ohara O, Kaneko H, Kondo N.
    J Clin Immunol; 2014 Aug 24; 34(6):691-5. PubMed ID: 24906628
    [Abstract] [Full Text] [Related]

  • 13. Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy.
    Korzycka J, Pawłowicz-Szlarska E, Masajtis-Zagajewska A, Nowicki M.
    Am J Case Rep; 2022 Oct 28; 23():e936565. PubMed ID: 36306276
    [Abstract] [Full Text] [Related]

  • 14. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
    Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ.
    Hum Mutat; 2010 Jun 28; 31(6):E1445-60. PubMed ID: 20513133
    [Abstract] [Full Text] [Related]

  • 15. Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.
    Józsi M, Reuter S, Nozal P, López-Trascasa M, Sánchez-Corral P, Prohászka Z, Uzonyi B.
    Immunol Lett; 2014 Aug 28; 160(2):163-71. PubMed ID: 24491679
    [Abstract] [Full Text] [Related]

  • 16. Atypical hemolytic uremic syndrome and acute tubular necrosis induced by complement factor B gene (CFB) mutation: A case report.
    Wu H, Su S, Li L, Zhang L.
    Medicine (Baltimore); 2021 Mar 19; 100(11):e25069. PubMed ID: 33725982
    [Abstract] [Full Text] [Related]

  • 17. Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis.
    Aradottir SS, Kristoffersson AC, Roumenina LT, Bjerre A, Kashioulis P, Palsson R, Karpman D.
    Front Immunol; 2021 Mar 19; 12():690821. PubMed ID: 34177949
    [Abstract] [Full Text] [Related]

  • 18. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Osborne AJ, Breno M, Borsa NG, Bu F, Frémeaux-Bacchi V, Gale DP, van den Heuvel LP, Kavanagh D, Noris M, Pinto S, Rallapalli PM, Remuzzi G, Rodríguez de Cordoba S, Ruiz A, Smith RJH, Vieira-Martins P, Volokhina E, Wilson V, Goodship THJ, Perkins SJ.
    J Immunol; 2018 Apr 01; 200(7):2464-2478. PubMed ID: 29500241
    [Abstract] [Full Text] [Related]

  • 19. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
    Mohlin FC, Nilsson SC, Levart TK, Golubovic E, Rusai K, Müller-Sacherer T, Arbeiter K, Pállinger É, Szarvas N, Csuka D, Szilágyi Á, Villoutreix BO, Prohászka Z, Blom AM.
    Mol Immunol; 2015 Jun 01; 65(2):367-76. PubMed ID: 25733390
    [Abstract] [Full Text] [Related]

  • 20. Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report.
    Rysava R, Peiskerova M, Tesar V, Benes J, Kment M, Szilágyi Á, Csuka D, Prohászka Z.
    Front Immunol; 2022 Jun 01; 13():1001366. PubMed ID: 36275662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.